Pathogenesis of lupus-like nephritis through autoimmune antibody produced by CD180-negative B lymphocytes in NZBWF1 mouse

Immunology Letters

Volumn 144, Issue 1-2, 2012, Pages 1-6

  Fujita, Kazuko ^a   Akasaka, Yoshikiyo ^a   Kuwabara, Taku ^b   Wang, Bing ^c   Tanaka, Kaoru ^c   Kamata, Itaru ^d   Yokoo, Tomoko ^a   Kinoshita, Toshio ^d   Iuchi, Ami ^a   Akishima Fukasawa, Yuri ^a   Ishikawa, Yukio ^a   Kondo, Motonari ^b   Ishii, Toshiharu ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHO UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^d TOHO UNIVERSITY OMORI MEDICAL CENTER   (Japan)

Author keywords

B lymphocyte; CD180; Lupus like nephritis; NZBWF1 mouse; SLE

Indexed keywords

AUTOANTIBODY; DOUBLE STRANDED DNA ANTIBODY; HISTONE ANTIBODY; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; IMMUNOPATHOGENESIS; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTIC INFILTRATION; MORBIDITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN URINE LEVEL;

AGING; ANIMALS; ANTIGENS, CD; AUTOANTIBODIES; AUTOIMMUNE DISEASES; AUTOIMMUNITY; B-LYMPHOCYTES; CELLS, CULTURED; FEMALE; HUMANS; KIDNEY; LUPUS NEPHRITIS; MICE; MICE, INBRED BALB C; MICE, INBRED NZB; SPLEEN;

EID: 84862820761     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2012.02.012     Document Type: Article

References (32)

1. Marshak-Rothstein A. Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 2006, 6:823-835.
2. Papadimitraki E.D., Choulaki C., Koutala E., Bertsias G., Tsatsanis C., Gergianaki I., et al. Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process. Arthritis Rheum 2006, 54:3601-3611.
3. Green N.M., Marshak-Rothstein A. Toll-like receptor driven B cell activation in the induction of systemic autoimmunity. Semin Immunol 2011, 23:106-112.
4. Leadbetter E.A., Rifkin I.R., Hohlbaum A.M., Beaudette B.C., Shlomchik M.J., Marshak-Rothstein A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and toll-like receptors. Nature 2002, 416:603-607.
5. Nickerson K.M., Christensen S.R., Shupe J., Kashgarian M., Kim D., Elkon K., et al. TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus. J Immunol 2010, 184:1840-1848.
6. Lee T.P., Tang S.J., Wu M.F., Song Y.C., Yu C.L., Sun K.H. Transgenic overexpression of anti-double-stranded DNA autoantibody and activation of toll-like receptor 4 in mice induce severe systemic lupus erythematosus syndromes. J Autoimmun 2010, 35:358-367.
7. Lartigue A., Colliou N., Calbo S., Francois A., Jacquot S., Arnoult C., et al. Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus. J Immunol 2009, 183:6207-6216.
8. Chan V.W., Mecklenbräuker I., Su I., Texido G., Leitges M., Carsetti R., et al. The molecular mechanism of B cell activation by toll-like receptor protein RP-105. J Exp Med 1998, 188:93-101.
9. Divanovic S., Trompette A., Atabani S.F., Madan R., Golenbock D.T., Visintin A., et al. Negative regulation of toll-like receptor 4 signaling by the toll-like receptor homolog RP105. Nat Immunol 2005, 6:571-578.
10. Miyake K., Yamashita Y., Hitoshi Y., Takatsu K., Kimoto M. Murine B cell proliferation and protection from apoptosis with an antibody against a 105-kD molecule: unresponsiveness of X-linked immunodeficient B cells. J Exp Med 1994, 180:1217-1224.
11. Miyake K., Yamashita Y., Ogata M., Sudo T., Kimoto M. RP105, a novel B cell surface molecule implicated in B cell activation, is a member of the leucine-rich repeat protein family. J Immunol 1995, 154:3333-3340.
12. Miura Y., Miyake K., Yamashita Y., Shimazu R., Copeland N.G., Gilbert D.J., et al. Molecular cloning of a human RP105 homologue and chromosomal localization of the mouse and human RP105 genes (Ly64 and LY64). Genomics 1996, 38:299-304.
13. Yamashita Y., Miyake K., Miura Y., Kaneko Y., Yagita H., Suda T., et al. Activation mediated by RP105 but not CD40 makes normal B cells susceptible to anti-IgM-induced apoptosis: a role for fc receptor coligation. J Exp Med 1996, 184:113-120.
14. Roshak A.K., Anderson K.M., Holmes S.D., Jonak Z., Bolognese B., Terrett J., et al. Anti-human RP105 sera induces lymphocyte proliferation. J Leukoc Biol 1999, 65:43-49.
15. Ogata H., Su I., Miyake K., Nagai Y., Akashi S., Mecklenbrauker I., et al. The toll-like receptor protein RP105 regulates lipopolysaccharide signaling in B cells. J Exp Med 2000, 192:23-29.
16. Divanovic S., Trompette A., Petiniot L.K., Allen J.L., Flick L.M., Belkaid Y., et al. Regulation of TLR4 signaling and the host interface with pathogens and danger: the role of RP105. J Leukoc Biol 2007, 82:265-271.
17. Koarada S., Tada Y., Ushiyama O., Morito F., Suzuki N., Ohta A., et al. B cells lacking RP105, a novel B cell antigen, in systemic lupus erythematosus. Arthritis Rheum 1999, 42:2593-2600.
18. Kikuchi Y., Koarada S., Tada Y., Ushiyama O., Morito F., Suzuki N., et al. Difference in B cell activation between dermatomyositis and polymyositis: analysis of the expression of RP105 on peripheral blood B cells. Ann Rheum Dis 2001, 60:1137-1140.
19. Koarada S., Tada Y., Kikuchi Y., Ushiyama O., Suzuki N., Ohta A., et al. CD180 (RP105) in rheumatic diseases. Rheumatology 2001, 40:1315-1316.
20. Kikuchi Y., Koarada S., Tada Y., Ushiyama O., Morito F., Suzuki N., et al. RP105-lacking B cells from lupus patients are responsible for the production of immunoglobulins and autoantibodies. Arthritis Rheum 2002, 46:3259-3265.
21. Koarada S., Tada Y., Sohma Y., Haruta Y., Suematsu R., Mitamura M., et al. Autoantibody-producing RP105(-) B cells, from patients with systemic lupus erythematosus, showed more preferential expression of BCMA compared with BAFF-R than normal subjects. Rheumatology 2010, 49:662-670.
22. Koarada S., Ide M., Haruta Y., Tada Y., Ushiyama O., Morito F., et al. Two cases of antinuclear antibody negative lupus showing increased proportion of B cells lacking RP105. J Rheumatol 2005, 32:562-564.
23. Cassese G., Lindenau S., de Boer B., Arce S., Hauser A., Riemekasten G., et al. Inflamed kidneys of NZB/W mice are a major site for the homeostasis of plasma cells. Eur J Immunol 2001, 31:2726-2732.
24. Kasagi S., Kawano S., Okazaki T., Honjo T., Morinobu A., Hatachi S., et al. Anti-programmed cell death 1 antibody reduces CD4+PD-1+T cells and relieves the lupus-like nephritis of NZB/W F1 mice. J Immunol 2010, 184:2337-2347.
25. Boucher A., Droz D., Adafer E., Noel L.H. Characterization of mononuclear cell subsets in renal cellular interstitial infiltrates. Kidney Int 1986, 29:1043-1049.
26. Alexopoulos E., Seron D., Hartley R.B., Cameron J.S. Lupus nephritis: correlation of interstitial cells with glomerular function. Kidney Int 1990, 37:100-109.
27. Kono D.H., Theofilopoulos A.N. Genetics of SLE in mice. Springer Semin Immunopathol 2006, 28:83-96.
28. Perry D., Sang A., Yin Y., Zheng Y.Y., Morel L. Murine models of systemic lupus erythematosus. J Biomed Biotechnol 2011, 2:1-20.
29. Hirano T., Ishihara K., Hibi M. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 2000, 19:2548-2556.
30. Alleen T.C. Hematoxylin and eosin. Laboratory methods in histotechnology 1994, 53-54. The Armed Forces Institute of Pathology Press, Washington, DC. E.B. Pfophet, B. Mills, J.B. Arrington, L.H. Sobin (Eds.).
31. Gaffney E. Periodic acid shiff procedure. Laboratory methods in histotechnology 1994, The Armed Forces Institute of Pathology Press, Washington, DC, pp. 151-152. E.B. Pfophet, B. Mills, J.B. Arrington, L.H. Sobin (Eds.).
32. Bluestone J.A., Auchincloss H., Nepom G.T., Rotrosen D., St. Clair E.W., Turka L.A. The immune tolerance network at 10 years: tolerance at the bedside. Nat Rev Immunol 2010, 10:797-803.